Tamura, Tomohide
St. Luke's International Hospital Tokyo,
Japan
2025 Rank: 105957
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 4073 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105957 | 113243 |
| Total Cites | 21294 | 23075 |
| H-index | 67 | 72 |
| Hm-index | 18 | 20 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 307 | 333 |
| Number of Single+First+Last Authored Papers | 171 | 171 |
| Total Cites to Single+First+Last Authored Papers | 6283 | 6873 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17597 | 18522 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
7.72%
|
|
Tamura, Tomohide
St. Luke's International Hospital Tokyo,
Japan
2024 Rank: 100999
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3934 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100999 | 108629 |
| Total Cites | 20369 | 22118 |
| H-index | 65 | 69 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 304 | 330 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 5928 | 6494 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16818 | 17720 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
7.91%
|
|
Tamura, Tomohide
St. Luke's International Hospital Tokyo,
Japan
2023 Rank: 96297
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3803 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 96297 | 103327 |
| Total Cites | 19683 | 21394 |
| H-index | 63 | 67 |
| Hm-index | 18 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 298 | 324 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 5496 | 6026 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16238 | 17117 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
8.00%
|
|
Tamura, Tomohide
St. Luke's International Hospital Tokyo,
Japan
2022 Rank: 92151
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3663 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92151 | 97575 |
| Total Cites | 18569 | 20217 |
| H-index | 61 | 66 |
| Hm-index | 17 | 19 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 287 | 313 |
| Number of Single+First+Last Authored Papers | 163 | 163 |
| Total Cites to Single+First+Last Authored Papers | 4992 | 5479 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 15288 | 16130 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
8.15%
|
|
Tamura, Tomohide
St. Luke's International Hospital Tokyo,
Japan
2021 Rank: 89229
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3573 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89229 | 96226 |
| Total Cites | 17831 | 19440 |
| H-index | 60 | 64 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 16 | 16 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 283 | 309 |
| Number of Single+First+Last Authored Papers | 158 | 158 |
| Total Cites to Single+First+Last Authored Papers | 4702 | 5176 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14705 | 15524 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
8.28%
|
|
Tamura, Tomohide
St. Luke's International Hospital Tokyo,
Japan
2020 Rank: 88856
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 3717 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 88856 | 95193 |
| Total Cites | 16431 | 17936 |
| H-index | 58 | 61 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 12 | 12 |
| Total Cites to Single+First Authored Papers | 271 | 296 |
| Number of Single+First+Last Authored Papers | 153 | 153 |
| Total Cites to Single+First+Last Authored Papers | 4065 | 4470 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13545 | 14312 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.25 |
| Self-Citation Percentage |
8.39%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.